Massachusetts Financial Services
CLVS

Massachusetts Financial Services’s Clovis Oncology, Inc. CLVS Stock Holding History

Massachusetts Financial Services’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-126,849
Closed -$256K – 903
2022
Q1 		$256K Buy
126,849
+1,302
+1% +$2.56K ﹤0.01% 851
2021
Q4 		$340K Sell
125,547
-2,541
-2% -$9.39K ﹤0.01% 870
2021
Q3 		$571K Sell
128,088
-1,681
-1% -$8.1K ﹤0.01% 867
2021
Q2 		$753K Buy
129,769
+1,113
+0.9% +$6.52K ﹤0.01% 861
2021
Q1 		$903K Sell
128,656
-15,247
-11% -$102K ﹤0.01% 843
2020
Q4 		$691K Sell
143,903
-1,444
-1% -$7.3K ﹤0.01% 823
2020
Q3 		$847K Buy
+145,347
New +$870K ﹤0.01% 791

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Massachusetts Financial Services's CLVS Position: Q2 2022 in Review

Massachusetts Financial Services sold out of Clovis Oncology, Inc. (CLVS) in Q2 2022, closing a stake of 126,849 shares — an estimated $256K sold.

Massachusetts Financial Services first reported a position in CLVS in Q3 2020 and held it in 7 quarters. The position peaked at $903K in Q1 2021. 115 funds tracked by Wall St. Rank hold CLVS as of Q2 2022.

  • Massachusetts Financial Services reported no remaining Clovis Oncology, Inc. position as of Q2 2022 after selling out during the quarter.
  • Massachusetts Financial Services sold 126,849 Clovis Oncology, Inc. shares in Q2 2022, an estimated $256K.
  • Massachusetts Financial Services first reported a position in Clovis Oncology, Inc. in Q3 2020 and held it in 7 quarters.
  • Massachusetts Financial Services's Clovis Oncology, Inc. position peaked at $903K in Q1 2021.
  • 115 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2022.

Based on Massachusetts Financial Services's 13F filing for Q2 2022, filed 9 Aug 2022.